Table 1 Basic information of the included studies
Study | Design | No. of | Preoperative renal function | Age (year) | Male (%) | BMI (kg/m2) | Tumor Size (cm) | Follow-up (month) | Quality Score | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
cases, type | Creatinine | eGFR | CKD (%) | |||||||||
Turna2009 | P | 36 PN | 1.2 | 65 | 63.9 | 60.3 | 58 | 30.5 | 3.7 | 42.8 | 8 | |
| Â | Â | 36 CA | 1.4 | 52.3 | 55.6 | 64.1 | 64 | 31.3 | 2.5 | 28.0 | Â | |
Goyal2011 | R | 15 PN | 1.5 | 55.1 | 60 | 65.2 | 86.7 | NA | 3.4 | 30.8 | 9 | |
| Â | Â | 23 CA | 1.3 | 54.6 | 65.2 | 68.4 | 56.5 | NA | 2.5 | 31.2 | Â | |
Haber2011 | R | 48 PN | 1.2 | 61.6 | NA | 60.6 | 25 | 30.1 | 3.2 | 42.7 | 8 | |
| Â | Â | 30 CA | 1.5 | 53.8 | NA | 60.9 | 22 | 31.5 | 2.6 | 60.2 | Â | |
Kamol2013 | R | 33 PN | 1.2 | 62 | 42 | 60 | 67 | 29.0 | 3.0 | NA | 8 | |
| Â | Â | 43 CA | 1.3 | 57 | 70 | 64.4 | 81 | 29.0 | 2.3 | NA | Â | |
Bhindi2017 | P | 64PN | NA | 60.2 | NA | 62.6 | 73 | NA | 3.6 | NA | 9 | |
| Â | Â | 54CA | NA | 57.8 | NA | 64.6 | 75 | NA | 4.1 | NA | Â | |
BeKSaC2022 | R | 31PN | NA | 58 | 52 | 60.4 | 55 | 31 | 2.8 | NA | 8 | |
| Â | Â | 43CA | NA | 56 | 70 | 67.3 | 72 | 28 | 2.1 | NA | Â | |
Yasuda2022 | R | 842PN | NA | 57.4 | NA | 64.7 | 64 | 29 | 4.0 | 58.7 | 9 | |
| Â | Â | 102CA | NA | 52.6 | NA | 65.9 | 68 | 31 | 2.3 | 52.0 | Â | |